Background <p>Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by pathogenic <i>ATM</i> gene variants, characterised by progressive cerebellar ataxia, telangiectasia, immunodeficiency, and cancer predisposition. While its immunological and oncological complications are well-documented, clinical heterogeneity, particularly in cases with elevated IgM, poses diagnostic challenges.</p> Methods <p>Following written informed consent, we retrospectively analysed four pediatric A-T patients followed in our clinic. Clinical, laboratory, and radiological data were reviewed, including immunoglobulin levels, vaccine antibody responses, lymphocyte subsets, and alpha-fetoprotein (AFP) levels. Diagnosis was established based on clinical and laboratory findings, supported by whole-exome sequencing (WES) and targeted <i>ATM</i> gene sequencing.</p> Results <p>Our findings further support the association between the hyper-IgM phenotype and increased immune dysfunction in A-T. We report the first globally documented case of lupus vulgaris in an A-T patient and identify a previously unreported ATM variant in our country, expanding the disease spectrum. These findings highlight the need for further research on regional genetic variations and their clinical implications.</p> Conclusion <p>This study highlights the importance of early diagnosis and genetic testing, particularly in atypical presentations. The recognition of novel infectious and autoimmune associations, along with novel variants, underscores the necessity of comprehensive, multidisciplinary follow-up and regional genetic screening efforts.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Expanding the clinical spectrum of pediatric ataxia-telangiectasia: a case series of novel genetic variants, lupus vulgaris, and hyper-IgM phenotypes

  • Damla Baysal Bakır,
  • Özge Atay,
  • Halime Yağmur,
  • Gizem Kabadayı,
  • Mehmet Kocabey,
  • Suna Asilsoy,
  • Nevin Uzuner

摘要

Background

Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by pathogenic ATM gene variants, characterised by progressive cerebellar ataxia, telangiectasia, immunodeficiency, and cancer predisposition. While its immunological and oncological complications are well-documented, clinical heterogeneity, particularly in cases with elevated IgM, poses diagnostic challenges.

Methods

Following written informed consent, we retrospectively analysed four pediatric A-T patients followed in our clinic. Clinical, laboratory, and radiological data were reviewed, including immunoglobulin levels, vaccine antibody responses, lymphocyte subsets, and alpha-fetoprotein (AFP) levels. Diagnosis was established based on clinical and laboratory findings, supported by whole-exome sequencing (WES) and targeted ATM gene sequencing.

Results

Our findings further support the association between the hyper-IgM phenotype and increased immune dysfunction in A-T. We report the first globally documented case of lupus vulgaris in an A-T patient and identify a previously unreported ATM variant in our country, expanding the disease spectrum. These findings highlight the need for further research on regional genetic variations and their clinical implications.

Conclusion

This study highlights the importance of early diagnosis and genetic testing, particularly in atypical presentations. The recognition of novel infectious and autoimmune associations, along with novel variants, underscores the necessity of comprehensive, multidisciplinary follow-up and regional genetic screening efforts.